⌕
Abbott Laboratories · ABT · NYSE
Tenet 45 · Mixed
Compare
$107.45−0.99%At closeTenet 45 · Mixed
$107.45−1.07 (−0.99%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$107.450.00 (0.00%)
After hours: Nov 16, 2026, 6:03 PM ET

Abbott Laboratories (ABT) Institutional Ownership

13F filers reported holding 81.0% of Abbott Laboratories (ABT) shares as of Jun 30, 2026, across 3,009 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
81.0%
Jun 30, 2026
13F filers
3,009
quarter ended Jun 30, 2026
13F value
$127.4B
1.4B shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 3,009 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 5, 2026Moreland Mary KEXECUTIVE VICE PRESIDENTDisposed · Open-market sale3,500Common shares without par value$116.00↗
Sep 30, 2026Stratton John GdirectorAcquired · Grant / award397Stock Equivalent Units$98.83↗
Sep 30, 2026Gonzalez Patricia P.directorAcquired · Grant / award333Stock Equivalent Units$98.83↗
Sep 30, 2026Conroy Kevin TdirectorAcquired · Grant / award318Stock Equivalent Units$98.83↗
Sep 30, 2026Ahuja NitadirectorAcquired · Grant / award318Stock Equivalent Units$98.83↗
Sep 30, 2026Roman Michael FdirectorAcquired · Grant / award381Stock Equivalent Units$98.83↗
Sep 2, 2026MCCOY JOHN A.VICE PRESIDENT AND CONTROLLERDisposed · Open-market sale27Common shares without par value$109.54↗
Sep 1, 2026Boudreau Philip PEVP AND CFODisposed · Tax withholding388Common shares without par value$110.36↗
Sep 1, 2026MCCOY JOHN A.VICE PRESIDENT AND CONTROLLERDisposed · Tax withholding52Common shares without par value$110.36↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEOAcquired · Option exercise151,869Common shares without par value$44.40↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEOAcquired · Option exercise246,963Common shares without par value$59.94↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEODisposed · Open-market sale218,535Common shares without par value$115.57↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEODisposed · Open-market sale180,297Common shares without par value$116.19↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEODisposed · Option exercise151,869Option (right to buy)—↗
Aug 25, 2026Ford Robert BCHAIRMAN AND CEODisposed · Option exercise246,963Option (right to buy)—↗
Aug 12, 2026Morrone Louis H.EXECUTIVE VICE PRESIDENTDisposed · Discretionary12Common shares without par value$107.99↗
Aug 11, 2026Morrone Louis H.EXECUTIVE VICE PRESIDENTDisposed · Open-market sale5,850Common shares without par value$109.83↗
Jun 30, 2026Ahuja NitadirectorAcquired · Grant / award347Stock Equivalent Units$90.74↗
Jun 30, 2026Gonzalez Patricia P.directorAcquired · Grant / award363Stock Equivalent Units$90.74↗
Jun 30, 2026Morrone Louis H.EXECUTIVE VICE PRESIDENTDisposed · Tax withholding269Common shares without par value$92.71↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Abbott Laboratories do institutions hold?

13F filers reported holding 81.0% of Abbott Laboratories' shares as of Jun 30, 2026, across 3,009 filers.

How many 13F filers hold Abbott Laboratories?

Abbott Laboratories was held by 3,009 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.